Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Cancer investigation
Published: October 10, 2025
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: June 24, 2022
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer.
Journal: Journal of geriatric oncology
Published: August 03, 2020
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Journal: Cancer immunology, immunotherapy : CII
Published: April 30, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
Journal: BMC cancer
Published: September 16, 2019
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Journal: Cancer immunology, immunotherapy : CII
Published: August 12, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
Journal: Journal of cancer research and clinical oncology
Published: June 17, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Journal: The Lancet. Oncology
Published: September 21, 2018
Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 10, 2017
Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations.
Journal: Case reports in pulmonology
Published: April 24, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026